{"response": {"meta": {"time": 14, "hits": 1, "offset": 0}, "docs": [{"news_desk": "Financial Desk", "document_type": "article", "_id": "4fd1825c8eb7c8105d67f889", "headline": {"main": "Drug Makers Try Biotech Partners"}, "pub_date": "1988-09-30T00:00:00Z", "slideshow_credits": null, "source": "The New York Times", "byline": {"original": "By MILT FREUDENHEIM", "person": [{"lastname": "FREUDENHEIM", "rank": 1, "firstname": "Milt", "organization": "", "role": "reported"}]}, "abstract": null, "web_url": "http://www.nytimes.com/1988/09/30/business/drug-makers-try-biotech-partners.html", "section_name": "Health; Business", "lead_paragraph": "LEAD: In the belief that the biotechnology industry is about to become a major source of important new drugs, the big pharmaceutical companies are racing to strengthen their ties to the industry's most promising members.", "snippet": "LEAD: In the belief that the biotechnology industry is about to become a major source of important new drugs, the big pharmaceutical companies are racing to strengthen their ties to the industry's most promising members.", "blog": [], "keywords": [{"value": "MARKETING AND MERCHANDISING", "name": "subject"}, {"value": "RESEARCH", "name": "subject"}, {"value": "NEW MODELS, DESIGN AND PRODUCTS", "name": "subject"}, {"value": "BIOTECHNOLOGY", "name": "subject"}, {"value": "DRUGS AND DRUG TRADE", "name": "subject"}], "print_page": "1", "type_of_material": "News", "word_count": 1608, "subsection_name": null, "multimedia": []}]}, "status": "OK", "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}